CN116077357A - 一种含维生素e的婴幼儿保湿乳液及其制备方法 - Google Patents
一种含维生素e的婴幼儿保湿乳液及其制备方法 Download PDFInfo
- Publication number
- CN116077357A CN116077357A CN202310051524.2A CN202310051524A CN116077357A CN 116077357 A CN116077357 A CN 116077357A CN 202310051524 A CN202310051524 A CN 202310051524A CN 116077357 A CN116077357 A CN 116077357A
- Authority
- CN
- China
- Prior art keywords
- percent
- agent
- skin
- vitamin
- infant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 title claims abstract description 32
- 239000000839 emulsion Substances 0.000 title claims abstract description 26
- 230000003020 moisturizing effect Effects 0.000 title claims abstract description 24
- 229930003427 Vitamin E Natural products 0.000 title claims abstract description 16
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 title claims abstract description 16
- 229940046009 vitamin E Drugs 0.000 title claims abstract description 16
- 235000019165 vitamin E Nutrition 0.000 title claims abstract description 16
- 239000011709 vitamin E Substances 0.000 title claims abstract description 16
- 238000002360 preparation method Methods 0.000 title claims description 9
- 238000004945 emulsification Methods 0.000 title description 2
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 18
- 239000003906 humectant Substances 0.000 claims abstract description 15
- 239000003242 anti bacterial agent Substances 0.000 claims abstract description 14
- 150000001413 amino acids Chemical class 0.000 claims abstract description 13
- 239000002738 chelating agent Substances 0.000 claims abstract description 13
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 13
- 239000003755 preservative agent Substances 0.000 claims abstract description 13
- 230000002335 preservative effect Effects 0.000 claims abstract description 13
- 239000002904 solvent Substances 0.000 claims abstract description 13
- 239000003381 stabilizer Substances 0.000 claims abstract description 13
- 239000004094 surface-active agent Substances 0.000 claims abstract description 13
- 239000002562 thickening agent Substances 0.000 claims abstract description 13
- 239000006210 lotion Substances 0.000 claims abstract description 12
- 239000002994 raw material Substances 0.000 claims abstract description 11
- 125000003118 aryl group Chemical group 0.000 claims abstract description 7
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims abstract description 6
- 239000004902 Softening Agent Substances 0.000 claims abstract description 6
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 claims abstract description 6
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 claims abstract description 4
- RGUVUPQQFXCJFC-UHFFFAOYSA-N n-hydroxyoctanamide Chemical compound CCCCCCCC(=O)NO RGUVUPQQFXCJFC-UHFFFAOYSA-N 0.000 claims abstract description 4
- 239000000314 lubricant Substances 0.000 claims abstract description 3
- 238000003756 stirring Methods 0.000 claims description 17
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 6
- 239000003205 fragrance Substances 0.000 claims description 6
- 238000005303 weighing Methods 0.000 claims description 5
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 4
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical group CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 claims description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 229940015975 1,2-hexanediol Drugs 0.000 claims description 2
- QGJDXUIYIUGQGO-UHFFFAOYSA-N 1-[2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoyl]pyrrolidine-2-carboxylic acid Chemical group CC(C)(C)OC(=O)NC(C)C(=O)N1CCCC1C(O)=O QGJDXUIYIUGQGO-UHFFFAOYSA-N 0.000 claims description 2
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 claims description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical group OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 2
- 239000004475 Arginine Substances 0.000 claims description 2
- 229920002125 Sokalan® Polymers 0.000 claims description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 2
- 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 claims description 2
- 229960001631 carbomer Drugs 0.000 claims description 2
- 229940082500 cetostearyl alcohol Drugs 0.000 claims description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 2
- 229940100524 ethylhexylglycerin Drugs 0.000 claims description 2
- 235000011187 glycerol Nutrition 0.000 claims description 2
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical group CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims description 2
- 229940100460 peg-100 stearate Drugs 0.000 claims description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 2
- -1 polydimethylsiloxane Polymers 0.000 claims description 2
- 229960004063 propylene glycol Drugs 0.000 claims description 2
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 claims description 2
- 229940042585 tocopherol acetate Drugs 0.000 claims description 2
- 150000003712 vitamin E derivatives Chemical class 0.000 claims description 2
- 238000000034 method Methods 0.000 claims 5
- 201000008937 atopic dermatitis Diseases 0.000 abstract description 9
- 206010014198 Eczema infantile Diseases 0.000 abstract description 6
- 201000004624 Dermatitis Diseases 0.000 abstract description 5
- 230000000694 effects Effects 0.000 abstract description 5
- 208000003251 Pruritus Diseases 0.000 abstract description 4
- 208000010668 atopic eczema Diseases 0.000 abstract description 4
- 230000007803 itching Effects 0.000 abstract description 3
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 2
- 230000003064 anti-oxidating effect Effects 0.000 abstract description 2
- 230000004888 barrier function Effects 0.000 abstract description 2
- 230000002708 enhancing effect Effects 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 28
- 206010012438 Dermatitis atopic Diseases 0.000 description 3
- 239000003862 glucocorticoid Substances 0.000 description 2
- 230000000474 nursing effect Effects 0.000 description 2
- 229940037128 systemic glucocorticoids Drugs 0.000 description 2
- 206010003645 Atopy Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
Abstract
一种含维生素E的婴幼儿保湿乳液,包括以婴幼儿保湿乳液的总重量来计的原料:0.1~5%皮肤护理剂、0.01~0.1%氨基酸表面活性剂、5~20%保湿剂、0.5~2%高效乳化剂、0.5~2%乳化稳定剂、0.5~2%柔润剂、0.1~1%抗菌剂、0.01~0.05%螯合剂、0.2~2%防腐剂、0.01~0.1%芳香剂、0.1~0.5%增稠剂,其余为溶剂。本发明的有益之处在于:本发明的婴幼儿乳液针对婴幼儿及小儿湿疹的的皮肤特点,采用抗菌剂辛酰羟肟酸可以对皮肤湿疹处进行抗菌,缓解瘙痒;采用生育酚乙酸酯,具有增强细胞的抗氧化作用,与柔润剂和保湿剂配合,起到较好的滋润皮肤的作用,使皮肤保持顺滑清爽,能够很好地修复皮肤保护屏障。
Description
技术领域
本发明属于日化用品领域,具体的为一种含维生素E的婴幼儿保湿乳液及其制备方法。
背景技术
婴幼儿的皮肤具有角质层尚未发育完全、容易吸收外物、容易摩擦受损、调整酸碱能力差、皮肤的色素层单薄、调节能力弱等特点,需要开发适合的护肤品保护婴幼儿皮肤。因为在婴幼儿时期极易患皮肤湿疹,针对婴幼儿的皮肤特点,不仅需要考虑护肤品的安全性、对皮肤良好的护理性,还需要考虑对破损皮肤的修复作用。
小儿湿疹,即特应性皮炎(atopicdermatitis,AD),又称为遗传过敏性皮炎、异位性皮炎,是一种慢性、复发性、炎症性皮肤病。多于婴幼儿时期发病,并迁延至儿童和成人期。以湿疹样皮疹,伴剧烈瘙痒,反复发作为临床特点,病患本人或家族中常有明显的“特应性”,严重影响生活质量。市面上对于婴幼儿的小儿湿疹的治疗,大部分均添加了糖皮质激素类,其治疗效果较显著,但激素类药物存在一定的副作用,特别是对于婴幼儿一般不建议使用。现有技术中用于小儿湿疹的护肤品种类很少,缺少具有预防和护理作用的婴幼儿护肤产品。
发明内容
为了解决上述问题,本发明提供的技术方案为:一种含维生素E的婴幼儿保湿乳液,包括以婴幼儿保湿乳液的总重量来计的原料:0.1~5%皮肤护理剂、0.01~0.1%氨基酸表面活性剂、5~20%保湿剂、0.5~2%高效乳化剂、0.5~2%乳化稳定剂、0.5~2%柔润剂、0.1~1%抗菌剂、0.01~0.05%螯合剂、0.2~2%防腐剂、0.01~0.1%芳香剂、0.1~0.5%增稠剂,其余为溶剂。
优选方式下,所述皮肤护理剂为生育酚乙酸酯,又称维生素E醋酸酯,维生素E的一种衍生物。
所述氨基酸表面活性剂为精氨酸;
所述保湿剂为甘油和水的复配物或丙二醇、1,2-己二醇和乙基己基甘油的复配物;
所述高效乳化剂为甘油硬脂酸酯和PEG-100硬脂酸酯的复配物;
所述乳化稳定剂为鲸蜡硬脂醇聚醚-25;
所述柔润剂为聚二甲基硅氧烷;
所述抗菌剂为辛酰羟肟酸;
所述螯合剂为葡庚糖酸钠;
所述防腐剂为对羟基苯乙酮;
所述芳香剂为草本香精;
所述增稠剂为卡波姆;
所述溶剂为水。
一种含维生素E的婴幼儿保湿乳液的制备方法,包括以下步骤:
步骤1、所述原料按照配比进行称取,备用;
步骤2、在容器中依次加入溶剂、柔润剂、保湿剂、防腐剂和螯合剂后开启搅拌;
步骤3、再向容器中加入高效乳化剂、乳化稳定剂和增稠剂,均质搅拌溶解;
步骤4、再向容器中加入氨基酸表面活性剂、皮肤护理剂、芳香剂和抗菌剂,均质搅拌,震动除泡。
优选方式下,所述步骤2中的制备容器可采用本领域熟知的任何常规的混合设备,如:搅拌锅等。
本发明的有益之处在于:本发明的婴幼儿乳液针对婴幼儿及小儿湿疹的的皮肤特点,采用抗菌剂辛酰羟肟酸可以对皮肤湿疹处进行抗菌,缓解瘙痒;采用生育酚乙酸酯,具有增强细胞的抗氧化作用,与柔润剂和保湿剂配合,起到较好的滋润皮肤的作用,使皮肤保持顺滑清爽,能够很好地修复皮肤保护屏障;
本发明的婴幼儿保湿乳液肤感细腻爽滑、保湿、修护皮肤屏障、缓解瘙痒,兼具了修复与护理功效,能够提高婴幼儿皮肤抵抗外界刺激以及过敏原侵害。
具体实施方式
实施例1
一种含维生素E的婴幼儿保湿乳液,包括以婴幼儿保湿乳液的总重量来计的原料:1%皮肤护理剂、0.08%氨基酸表面活性剂、10%保湿剂、0.8%高效乳化剂、0.8%乳化稳定剂、1.5%柔润剂、0.2%抗菌剂、0.03%螯合剂、0.5%防腐剂、0.02%芳香剂、0.2%增稠剂,其余为溶剂。
一种含维生素E的婴幼儿保湿乳液的制备方法,包括以下步骤:
步骤1、所述原料按照配比进行称取,备用;
步骤2、在容器中依次加入溶剂、柔润剂、保湿剂、防腐剂和螯合剂后开启搅拌;
步骤3、再向容器中加入高效乳化剂、乳化稳定剂和增稠剂,均质搅拌溶解;
步骤4、再向容器中加入氨基酸表面活性剂、皮肤护理剂、芳香剂和抗菌剂,均质搅拌,震动除泡。
实施例2
一种含维生素E的婴幼儿保湿乳液,包括以婴幼儿保湿乳液的总重量来计的原料:2%皮肤护理剂、0.06%氨基酸表面活性剂、18%保湿剂、1%高效乳化剂、1%乳化稳定剂、1%柔润剂、0.5%抗菌剂、0.03%螯合剂、1%防腐剂、0.02%芳香剂、0.3%增稠剂,其余为溶剂。
一种含维生素E的婴幼儿保湿乳液的制备方法,包括以下步骤:
步骤1、所述原料按照配比进行称取,备用;
步骤2、在容器中依次加入溶剂、柔润剂、保湿剂、防腐剂和螯合剂后开启搅拌;
步骤3、再向容器中加入高效乳化剂、乳化稳定剂和增稠剂,均质搅拌溶解;
步骤4、再向容器中加入氨基酸表面活性剂、皮肤护理剂、芳香剂和抗菌剂,均质搅拌,震动除泡。
实施例3
一种含维生素E的婴幼儿保湿乳液,包括以婴幼儿保湿乳液的总重量来计的原料:4%皮肤护理剂、0.02%氨基酸表面活性剂、12%保湿剂、1.5%高效乳化剂、1.5%乳化稳定剂、0.8%柔润剂、0.8%抗菌剂、0.015%螯合剂、1.5%防腐剂、0.06%芳香剂、0.4%增稠剂,其余为溶剂。
一种含维生素E的婴幼儿保湿乳液的制备方法,包括以下步骤:
步骤1、所述原料按照配比进行称取,备用;
步骤2、在容器中依次加入溶剂、柔润剂、保湿剂、防腐剂和螯合剂后开启搅拌;
步骤3、再向容器中加入高效乳化剂、乳化稳定剂和增稠剂,均质搅拌溶解;
步骤4、再向容器中加入氨基酸表面活性剂、皮肤护理剂、芳香剂和抗菌剂,均质搅拌,震动除泡。
以上所述仅为本发明的最佳实施例,凡依本发明申请专利范围所做的均等变化与修饰,皆应属于本发明的涵盖范围。
Claims (4)
1.一种含维生素E的婴幼儿保湿乳液,其特征在于,包括以婴幼儿保湿乳液的总重量来计的原料:0.1~5%皮肤护理剂、0.01~0.1%氨基酸表面活性剂、5~20%保湿剂、0.5~2%高效乳化剂、0.5~2%乳化稳定剂、0.5~2%柔润剂、0.1~1%抗菌剂、0.01~0.05%螯合剂、0.2~2%防腐剂、0.01~0.1%芳香剂、0.1~0.5%增稠剂,其余为溶剂。
2.根据权利要求1所述的一种含维生素E的婴幼儿保湿乳液,其特征在于:
所述皮肤护理剂为生育酚乙酸酯,又称维生素E醋酸酯,维生素E的一种衍生物。
所述氨基酸表面活性剂为精氨酸;
所述保湿剂为甘油和水的复配物或丙二醇、1,2-己二醇和乙基己基甘油的复配物;
所述高效乳化剂为甘油硬脂酸酯和PEG-100硬脂酸酯的复配物;
所述乳化稳定剂为鲸蜡硬脂醇聚醚-25;
所述柔润剂为聚二甲基硅氧烷;
所述抗菌剂为辛酰羟肟酸;
所述螯合剂为葡庚糖酸钠;
所述防腐剂为对羟基苯乙酮;
所述芳香剂为草本香精;
所述增稠剂为卡波姆;
所述溶剂为水。
3.根据权利要求1所述的一种含维生素E的婴幼儿保湿乳液的制备方法,其特征在于:包括以下步骤:
步骤1、所述原料按照配比进行称取,备用;
步骤2、在容器中依次加入溶剂、柔润剂、保湿剂、防腐剂和螯合剂后开启搅拌;
步骤3、再向容器中加入高效乳化剂、乳化稳定剂和增稠剂,均质搅拌溶解;
步骤4、再向容器中加入氨基酸表面活性剂、皮肤护理剂、芳香剂和抗菌剂,均质搅拌,震动除泡。
4.根据权利要求3所述的一种含维生素E的婴幼儿保湿乳液的制备方法,其特征在于:所述步骤2中的制备容器可采用本领域熟知的任何常规的混合设备,如:搅拌锅等。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310051524.2A CN116077357A (zh) | 2023-02-02 | 2023-02-02 | 一种含维生素e的婴幼儿保湿乳液及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310051524.2A CN116077357A (zh) | 2023-02-02 | 2023-02-02 | 一种含维生素e的婴幼儿保湿乳液及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116077357A true CN116077357A (zh) | 2023-05-09 |
Family
ID=86209908
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310051524.2A Pending CN116077357A (zh) | 2023-02-02 | 2023-02-02 | 一种含维生素e的婴幼儿保湿乳液及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116077357A (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2663910C1 (ru) * | 2017-11-27 | 2018-08-13 | Акционерное общество "Косметическое объединение "СВОБОДА" (АО "СВОБОДА") | Косметический крем для защиты кожи детей от ветра и непогоды |
CN109091411A (zh) * | 2018-11-13 | 2018-12-28 | 王亚平 | 一种婴幼儿乳液及其制备方法 |
CN113648241A (zh) * | 2021-09-26 | 2021-11-16 | 广东瀚森生物科技有限公司 | 一种高保湿乳液及其制备方法 |
-
2023
- 2023-02-02 CN CN202310051524.2A patent/CN116077357A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2663910C1 (ru) * | 2017-11-27 | 2018-08-13 | Акционерное общество "Косметическое объединение "СВОБОДА" (АО "СВОБОДА") | Косметический крем для защиты кожи детей от ветра и непогоды |
CN109091411A (zh) * | 2018-11-13 | 2018-12-28 | 王亚平 | 一种婴幼儿乳液及其制备方法 |
CN113648241A (zh) * | 2021-09-26 | 2021-11-16 | 广东瀚森生物科技有限公司 | 一种高保湿乳液及其制备方法 |
Non-Patent Citations (1)
Title |
---|
福建省梦娇兰日用化学品有限公司: "小浣熊保湿维E乳", Retrieved from the Internet <URL:https://hzpba.nmpa.gov.cn/gccx/chakan.html?prodId=1164491465674457088&gb=G> * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110448486B (zh) | 一种可修复皮脂膜受损的精华油 | |
JP3763567B2 (ja) | 化粧料 | |
JP5453093B2 (ja) | 抗真菌医薬組成物 | |
CN110302087B (zh) | 修护组合物、应用及含有该修护组合物的护肤品组合物 | |
CN110638727B (zh) | 一种婴幼儿护臀组合物及其制备方法和应用 | |
JP2013236640A (ja) | 有機化合物の新規使用 | |
CN108042380A (zh) | 一种婴幼儿活性护臀霜及其制备方法 | |
CN108113894A (zh) | 一种婴幼儿活性润肤乳及其制备方法 | |
CN113925824B (zh) | 一种舒缓修护组合物及其制备方法 | |
CN111000766A (zh) | 氨基酸洁面膏及其制备方法 | |
CN111297713A (zh) | 抗敏修复护肤制剂 | |
US10500187B2 (en) | Composition comprising plant phenols for preventing or reducing TEWL and associated disorders and diseases | |
CN113181074B (zh) | 一种复合叶酸抗过敏抗刺激护肤组合物及其制备方法和应用 | |
CN109288729A (zh) | 一种婴儿用多效修护面霜 | |
CN116077357A (zh) | 一种含维生素e的婴幼儿保湿乳液及其制备方法 | |
JP2005350412A (ja) | 神経成長因子産生抑制剤、並びにその神経成長因子産生抑制剤を配合した皮膚外用剤、化粧料、医薬部外品、痒み予防及び治療剤、及びアトピー性皮膚炎治療剤 | |
KR102418101B1 (ko) | 패오니플로린 또는 알비플로린을 포함하는, 내인성 노화 예방 또는 개선용 조성물 | |
CN114306107B (zh) | 功效型皮肤用产品及其制备方法 | |
US20230037905A1 (en) | Topical composition comprising tofacitinib and fingolimod | |
CN114404466A (zh) | 一种基于依克多因的鼻腔修护组合物及其制备方法 | |
CN113576994A (zh) | 具有协同保湿舒缓效果的组合物、化妆品及其制备方法 | |
US10786441B2 (en) | Skin barrier repair and maintenance composition | |
KR20110006890A (ko) | 필라그린 생성촉진을 위한 조성물 | |
JP6822648B2 (ja) | トリプターゼ阻害剤組成物 | |
CN113827509B (zh) | 一种辅酶q10眼霜及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |